Johnson & Johnson has proposed to pay $5.5 billion to resolve about 76,000 lawsuits alleging that its talc-based baby powder and other talcum products caused ovarian cancer — a landmark deal that could bring an end to litigation that has dogged the company for more than a decade.
The company announced the proposed resolution on Monday, July 27, 2026. J&J said the agreement covers roughly 99.75% of the remaining talc ovarian-cancer claims consolidated in federal court in New Jersey and in related state-court cases.
Important: This is a proposed settlement of claims that have already been filed. It is not a new, open claim process for the general public, and it is not yet final. J&J continues to deny that its products cause cancer.
What J&J agreed to pay
Under the proposal, J&J would pay an estimated $5.5 billion, structured as:
- an initial payment of no more than $3 billion in 2027; and
- the remaining payments made by 2028.
Plaintiffs’ lawyers have said the total could rise depending on how many claimants participate. The company said the accelerated schedule is intended to pay nearly all claims within roughly 18 months, rather than being spread over more than a decade as earlier bankruptcy proposals would have been.
The deal is conditional and not yet final
The proposed settlement is contingent on at least 95% of the ovarian-cancer claimants in state and federal court accepting the terms. If that threshold is not met, the agreement may not take effect.
It is also limited in scope. According to J&J, the deal applies only to existing claims — it does not resolve or provide a fund for future lawsuits.
Why the settlement is happening now
The proposal follows a July 22, 2026 ruling by U.S. Magistrate Judge Rukhsanah Singh in the New Jersey multidistrict litigation, which ordered plaintiffs to show cause why the talc cases should not be dismissed after lead plaintiffs’ lawyers withdrew two key expert witnesses on specific causation.
It also comes after years of contested litigation, including dozens of trial verdicts for both sides and three failed attempts by J&J subsidiaries to resolve the claims through bankruptcy — a strategy critics called the “Texas two-step.” A roughly $9–10 billion bankruptcy settlement proposed by a J&J subsidiary was dismissed by a federal court in 2025.
What both sides are saying
Erik Haas, J&J’s worldwide vice president of litigation, said in a statement that the allegations “lack scientific merit” and that “studies show talc is safe, does not contain asbestos and does not cause cancer.” He said that while the company was “confident it would have ultimately prevailed with further litigation,” the resolution “allows the company to put this matter behind it.”
Plaintiffs’ lead counsel Chris Seeger said the settlement “ensures plaintiffs receive fair and meaningful compensation for their injuries,” adding that “more than a decade of protracted litigation and three failed bankruptcies has left tens of thousands of women and their families waiting far too long for relief.”
Background on the talc litigation
Lawsuits over J&J’s talc-based baby powder date back roughly 15 years, with claimants alleging the products were contaminated with asbestos or otherwise caused ovarian cancer and mesothelioma. J&J stopped selling talc-based baby powder in the United States and Canada in 2020 and worldwide in 2023, transitioning to a cornstarch-based formula. The company has said it made those changes as a commercial decision and has consistently denied that its products are unsafe.
J&J had previously settled most of the claims alleging its talc contained asbestos and caused mesothelioma. Its former consumer-health business, Kenvue, holds liability for the baby powder outside North America.
What this settlement does not cover
The proposed U.S. settlement does not cover a separate case in the United Kingdom, where a product-liability claim covering thousands of potential claimants was filed in October 2025. That case, which alleges J&J knew its talc could cause ovarian cancer and mesothelioma, is being handled by the UK courts and is unaffected by the U.S. proposal. J&J denies those allegations as well.
What consumers should know now
If you already have a filed talc claim, whether and how the proposed settlement affects you depends on the terms your attorney receives and the participation threshold being met. Claimants should speak with their own lawyers about their options.
There is currently no general public claim form or open claim deadline tied to this proposal for people who have not already filed. This article is not legal or medical advice.
Class Action Pulse will update this article as the participation threshold is confirmed, the court reviews the proposal, or an official process is announced.